Compare Nabla vs PathAI

Both tools in AI Healthcare

Nabla

Ambient AI assistant for clinicians that converts patient conversations into structured notes, coding suggestions, and EHR-ready documentation.

0 upvotesbeginner

PathAI

AI-powered digital pathology platform that automates slide analysis, biomarker quantification, and drug development support for labs and biopharma.

0 upvotesadvanced
Pricing

Pricing Comparison

NablaNabla
Free Trial$0

Full feature access for a limited period

Pro$Custom/month

Full access, priority support, EHR integration

Enterprise$Custom

Multi-site deployment, dedicated success team

PathAIPathAI
Enterprise$Custom

Annual licensing, cloud infrastructure, algorithm modules

Biopharma$Custom

Companion diagnostic development, clinical trial services, data licensing

Features

Feature Comparison

NablaNabla
Ambient Conversation CaptureSpecialty-Specific SOAP NotesLive Transcript ViewReferral Letter GenerationPatient-Facing Visit SummaryMedical Coding SuggestionsCustom Dot PhrasesNote Formatting Customization40+ EHR IntegrationsNative Epic Integrationathenahealth IntegrationMultilingual Encounter SupportCustom Note InstructionsChrome Extension AvailabilityiOS and Android AppNo Audio Storage by DefaultSOC 2 Type 2 and ISO 27001 Certified
PathAIPathAI
AISight Digital Pathology PlatformWhole Slide Image ManagementAI Tumor Detection AlgorithmsBiomarker Quantification (PD-L1, HER2)MASH AI Assist (FDA and EMA Qualified)Companion Diagnostic DevelopmentPrecision Pathology Network AccessPLUTO Foundation ModelExplore Biomarker Discovery SuiteLIS IntegrationCase Management AutomationRemote Consultation and AnnotationGCP and GCLP Compliant Lab ServicesFDA-Cleared AISight Dx PlatformClinical Trial Patient StratificationReal-World Data MonetizationPathologist Network (450+ contributors)
Fit

Best For & Not For

NablaNabla
✅ Best For
✅Clinicians across primary care, psychiatry, emergency medicine, and 35+ other specialties who want a fast, easy-to-deploy AI scribe without a lengthy enterprise rollout. Individual physicians and small practices that want a free trial before committing, and larger health organizations looking for HIPAA-certified ambient documentation with native EHR integrations.
❌ Not For
❌Users who need advanced revenue cycle automation or pre-visit intelligence modules alongside basic documentation. Health systems that require on-premises deployment rather than a cloud-based SaaS solution.
PathAIPathAI
✅ Best For
✅Anatomic pathology laboratories at academic medical centers, reference labs, and health systems looking to digitize workflows and deploy AI-powered diagnostic algorithms. Biopharma companies developing companion diagnostics, conducting clinical trials, or seeking AI-assisted biomarker discovery using validated pathology datasets.
❌ Not For
❌Individual clinicians or small outpatient practices without pathology laboratory operations. Organizations seeking ambient documentation or clinical note generation rather than digital pathology image analysis and drug development tools.
Availability

Platform & Accessibility

NablaNabla
web-basedmobilechrome-extensionapi
PathAIPathAI
web-basedapi
Use & Audience

Tasks & Who It's For

Integrations

Integrations

NablaNabla
Other
EpicathenahealthOracle HealthNextgen
PathAIPathAI
Other
Quest Diagnostics LISLabcorp LISPaigeVisiopharm
Use Cases

Real-world Use Cases

NablaNabla
1
Dr. Mischa, a psychologist, reduced her weekend charting from 10 hours to 3 hours after adopting Nabla, freeing time for family while improving note accuracy with less re-editing.
2
An emergency physician at a high-volume urban ER uses Nabla to document 14 patients per shift and says she cannot imagine going back to manual charting after 14 years without it.
3
Dr. Rivera, a vascular surgeon, uses Nabla for complex 30-minute consultations and receives a fully structured note in under 10 seconds that captures every problem and the complete care plan.
PathAIPathAI
1
A reference lab pathologist reviews 80 cases per day with AISight's AI-flagged priority queue, focusing attention on the highest-risk slides first and reducing average sign-out time by 35%.
2
A biopharma data scientist uses PathAI's Explore biomarker discovery suite to identify a novel spatial biomarker in a pancreatic cancer dataset of 12,000 slides that predicts immunotherapy response, advancing a Phase 2 trial design.
3
Labcorp deploys AISight Dx across its US pathology network after its expanded PathAI partnership, enabling digital workflows for case management, slide review, and AI-assisted annotation at scale.
Keep Exploring

Similar Comparisons